- Capital Cube•23 days agoElite Pharmaceuticals, Inc. :ELTP-US: Earnings Analysis: Q2, 2017 By the Numbers : November 11, 2016
Categories: Yahoo Finance Get free summary analysis Elite Pharmaceuticals, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Elite Pharmaceuticals, Inc. – Mylan N.V., Cambrex Corporation, Aceto Corporation, Nektar Therapeutics, Albany Molecular Research, Inc., Akorn, Inc. and Pfizer Inc. (MYL-US, CBM-US, ACET-US, NKTR-US, AMRI-US, AKRX-US and ... Read more (Read more...)
- GlobeNewswire•25 days agoElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2017 and Provides Conference Call Information
NORTHVALE, N.J., Nov. 09, 2016-- Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced results for the six months ended ...
- GlobeNewswire•27 days agoElite Pharmaceuticals, Inc. to Host Conference Call to Discuss 2nd Quarter 2017 Financial Results on November 10, 2016
NORTHVALE, N.J., Nov. 07, 2016-- Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche generic products, announced today that its second ...
ELTP : Summary for ELITE PHARMACEUTIC COM USD0.01 - Yahoo Finance
Elite Pharmaceuticals, Inc. (ELTP)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.14 - 0.15|
|52 Week Range||0.11 - 0.42|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-35.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|